Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Running Toward Progress: How Personify Health and Beyond Health Aim to Rewire Member Experience and Cost Control

As employer healthcare costs continue to rise heading into 2026, Personify Health and Beyond Health are combining data analytics, member advocacy, and payment integrity to improve engagement and control spending. Personify Health reports engagement rates above 50%, with members accessing its platform roughly 19 times per month. Together, the two organizations are working to reshape how employers manage benefits and member experience.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Healthcare · Beyond HealthDave ThomasEmployee BenefitsHealth Cost Reduction
Share

Key takeaways

01

Employer health costs are climbing, with member expectations reaching an all-time high ahead of 2026.

02

Personify Health reports 50%+ member engagement, with members interacting with the platform approximately 19 times per month.

03

Personify Health and Beyond Health are integrating data, advocacy, and payment integrity to reduce costs and improve member outcomes.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

In a year when employer health costs keep climbing and expectations are “at an all-time high” heading into 2026, Personify Health and Beyond Health are betting on a tighter fusion of data, advocacy, and payment integrity to change the trajectory. Personify reports engagement levels north of 50%, with members touching its platform 19 times per month, and support in 23 languages—signals that a more personal, always-on model can scale. With 26 million covered members informing its ecosystem choices, Personify says it can quickly evaluate and deploy best-in-class partners for pressing needs like cancer, MSK, and specialty infusion. The stakes: prove that proactive navigation plus rigorous claim review can bend trend—without asking sick or stressed members to “shop” the system alone.

Can a single, simplified “digital front door” paired with real-time advocacy and pre-payment claim integrity actually deliver better care experiences at lower total cost—for mid-market employers inside a captive model?

On this episode of Personify Health, host Dave Thomas, Senior Vice President of Integrated Benefits at Personify Health, sits down with John Kirk of Beyond Health. Together they unpack a new partnership focused on elevating member experience, tightening claim accuracy before dollars go out the door, and using live data to make mid-year course corrections—rather than waiting for open enrollment.

Key Takeaways from the Episode:

  • From “shop for care” to “walk-with navigation.” Why replacing passive transparency tools with real-time, multilingual advocacy (23 languages) and a unified app—ID cards, out-of-pocket, find-care, benefits, even 401(k) and payroll—meets members where they are and boosts engagement (50%+; 19 touches/month).
  • Turning invisible patterns into mid-year action. Using shared data rails across clinical, service, and reporting to surface trends in calls, claims, and conditions—then intervening quarterly or monthly on cancer, MSK, circulatory risk, pharmacy, and specialty infusion rather than waiting a year.
  • Claim integrity as a first-90-days muscle. Combining physician-aligned clinical review with AI to flag errors, upcoding, and inappropriate services—including lower-dollar claims—and to respond quickly under No Surprises Act timelines, protecting plan and captive dollars pre-payment.

John Kirk oversees healthcare captives at Beyond Health. With a career rooted in the insurance industry, the past ~15 years of his work have focused on helping employers understand and adopt captive insurance structures. Kirk leads Beyond Health’s strategy to arm mid-market employers with a “toolbox” of risk and cost mitigation programs—integrated with partner platforms—to outperform traditional market options.

Article written by MarketScale.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

H
Healthcare
PH
Personify Health

Personify Health

Personify Health is a health engagement and wellbeing platform that reports member engagement levels above 50%, with members interacting with its platform an average of 19 times per month. The company combines data-driven personalization with advocacy services to improve member health outcomes and employer cost management.

BH
Beyond Health

Beyond Health

Beyond Health is a health solutions company focused on payment integrity and member advocacy, working alongside employers to control rising healthcare costs. The company aims to improve the member experience through tighter integration of data and claims management.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512